The US Food and Drug Administration (FDA) has cleared two minimally invasive, catheter-based devices to create arteriovenous (AV) fistulas percutaneously in patients with chronic kidney disease who ...
In a recent study of older patients with end-stage kidney disease living in Europe, researchers found o ne-third received an ...
Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — In this video exclusive, Tony Das, MD, an interventional cardiologist at Walnut Hill Medical Center, ...
SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)--Avenu Medical, Inc. announced today that it has received De Novo marketing authorization from the Food and Drug Administration (FDA) to market its ...
early-dialysis-av-fistula-graft-surgery In the first few months of hemodialysis, one additional provider visit per month increased the probability of AV fistula or graft surgery by nearly 5%. When ...
Repeated dialysis needling can cause painful aneurysmal fistulas that must be removed. A new, minimally invasive approach will decrease morbidity amonghemodialysis patients and help improve their ...
Proven percutaneous AV fistula technology set to re-enter the market with phased rollout in 2026 ...
FRANKLIN LAKES, N.J., April 29, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that enrollment has begun and the ...
The endoscopic device manufactured by Maquet was originally developed for harvesting of the saphenous vein and radial artery as conduits for coronary artery bypass graft surgery. These vessels are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results